Skip to main content
Clinical Trials/DRKS00010498
DRKS00010498
Completed
Not Applicable

The DIAbetes COhoRtE - DIACORE

niversitätsklinikum Regensburg0 sites3,000 target enrollmentMay 23, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
E11
Sponsor
niversitätsklinikum Regensburg
Enrollment
3000
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 23, 2017
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Regensburg

Eligibility Criteria

Inclusion Criteria

  • Ability to provide written informed
  • consent, age \=18 years, self\-reported Caucasian ethnicity
  • and prevalent diabetes mellitus type 2\. Diabetes mellitus
  • type 2 is defined as need for blood glucose lowering medication,
  • at least two measurements of fasting glucose \=126
  • mg/dL or a 2\-hour glucose value in OGTT \>200 mg/dL. Criteria for diagnosis of diabetes mellitus type 2 are
  • obtained by self\-report or from clinical records obtained
  • from the patients’ health care provider.

Exclusion Criteria

  • Patients are excluded if, at baseline, they are on chronic
  • renal replacement therapy (hemodialysis, peritoneal dialysis
  • or transplantation), if, at baseline, there is a history of active
  • malignancy (except those with basal cell carcinoma)
  • within the last five years (prostatic cancer within the
  • last two years), autoimmune disease potentially affecting
  • kidney function (e.g. systemic lupus erythematodes),
  • hemochromatosis, history of pancreoprivic or self\-reported
  • type 1 diabetes mellitus, acute infection or fever, pregnancy,
  • chronic viral hepatitis or HIV\-infection.

Outcomes

Primary Outcomes

Not specified

Similar Trials